Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?

Lung Cancer

Volumn 53, Issue 3, 2006, Pages 323-330

  Park, Byeong Bae ^a   Park, Joon Oh ^a   Kim, Hojoong ^a   Ahn, Yong Chan ^b   Choi, Yong Soo ^b   Kim, Kwhanmien ^b   Kim, Jhingook ^b   Shim, Young Mog ^b   Ahn, Jin Seok ^a   Park, Keunchil ^a  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Chemoradiotherapy; Concurrent; Neoadjuvant; Non small cell lung cancer; Stage IIIA

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EDEMA; ESOPHAGITIS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEMOPTYSIS; HUMAN; INFECTION; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; MYALGIA; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PNEUMONIA; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PNEUMONIA; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

EID: 33746903555     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.05.024     Document Type: Article

References (35)

1. Pfister D.G., Johnson D.H., Azzoli C.G., Sause W., Smith T.J., Baker Jr. S., et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 22 (2004) 330-353
2. Dillman R.O., Seagren S.L., Propert K.J., Guerra J., Eaton W.L., Perry M.C., et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323 (1990) 940-945
3. Marino P., Preatoni A., and Cantoni A. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis. Cancer 76 (1995) 593-601
4. Albain K.S., Rusch V.W., Crowley J.J., Rice T.W., Turrisi III A.T., Weick J.K., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13 (1995) 1880-1892
5. Eberhardt W., Wilke H., Stamatis G., Stuschke M., Harstrick A., Menker H., et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol 16 (1998) 622-634
6. Trodella L., Granone P., Valente S., Margaritora S., Macis G., Cesario A., et al. Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging. Ann Oncol 15 (2004) 389-398
7. Weiden P.L., and Piantadosi S. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: a phase II study of the Lung Cancer Study Group. J Natl Cancer Inst 83 (1991) 266-273
8. Faber L.P., Kittle C.F., Warren W.H., Bonomi P.D., Taylor S.Gt., Reddy S., et al. Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann Thorac Surg 47 (1989) 669-675 (Discussion 76-7)
9. Rusch V.W., Albain K.S., Crowley J.J., Rice T.W., Lonchyna V., McKenna Jr. R., et al. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial. J Thorac Cardiovasc Surg 105 (1993) 97-104 (Discussion 6)
10. Thomas M., Rube C., Semik M., von Eiff M., Freitag L., Macha H.N., et al. Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 1185
11. Choi N.C., Carey R.W., Daly W., Mathisen D., Wain J., Wright C., et al. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol 15 (1997) 712-722
12. Kuten A., Anacak Y., Abdah-Bortnyak R., Chetver L., Zen Al Deen I., Daoud K., et al. Neoadjuvant radiotherapy concurrent with weekly paclitaxel and carboplatin and followed by surgery in locally advanced non-small-cell lung cancer. Am J Clin Oncol 26 (2003) 184-187
13. Martin J., Ginsberg R.J., Abolhoda A., Bains M.S., Downey R.J., Korst R.J., et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 72 (2001) 1149-1154
14. Furuse K., Fukuoka M., Kawahara M., Nishikawa H., Takada Y., Kudoh S., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
15. Ahn Y.C., Park K., Kim D.Y., Kim K.M., Kim J., Shim Y.M., et al. Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer. Acta Oncol 40 (2001) 588-592
16. Kang MK, Ahn YC, Lim DH, Park K, Park JO, Shim YM, et al. Preoperative concurrent radiochemotherapy and surgery for stage IIIA non-small cell lung cancer. J Korean Med Sci (in press).
17. Choy H., and MacRae R. The current state of paclitaxel and radiation in the combined-modality therapy of non-small cell lung cancer. Semin Oncol 28 (2001) 17-22
18. Clamon G., Herndon J., Cooper R., Chang A.Y., Rosenman J., and Green M.R. Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 17 (1999) 4-11
19. Belani C.P., Choy H., Bonomi P., Scott C., Travis P., Haluschak J., et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol. J Clin Oncol 23 (2005) 5883-5891
20. Katayama H., Ueoka H., Kiura K., Tabata M., Kozuki T., Tanimoto M., et al. Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer. Br J Cancer 90 (2004) 979-984
21. Choy H., Akerley W., and DeVore III R.F. Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer. Semin Oncol 26 (1999) 36-43
22. Betticher D.C., Hsu Schmitz S.F., Totsch M., Hansen E., Joss C., von Briel C., et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 21 (2003) 1752-1759
23. Depierre A., Milleron B., Moro-Sibilot D., Chevret S., Quoix E., Lebeau B., et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stages I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20 (2002) 247-253
24. Rosell R., Gomez-Codina J., Camps C., Javier Sanchez J., Maestre J., Padilla J., et al. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 26 (1999) 7-14
25. Roth J.A., Atkinson E.N., Fossella F., Komaki R., Bernadette Ryan M., Putnam Jr. J.B., et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21 (1998) 1-6
26. Wolf M., Faoro C., Goerg C., Pfab R., Havemann K., and Kettner H. Paclitaxel and simultaneous radiation in the treatment of stage IIIA/B non-small cell lung cancer. Semin Oncol 23 (1996) 108-112
27. Vogt H.G., Kolotas C., Martin T., Schneider L.V., Goes-Schmieder R., Mitrou P.S., et al. Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase I study. Semin Oncol 23 (1996) 120-123
28. Giannitto G.C., Giuffrida D., Pappalardo A., Russo A., Vincenzi B., Saita S., et al. Paclitaxel, carboplatin and gemcitabine combination as induction chemotherapy for stage IIIA N2 bulky non-small cell lung cancer. Oncology 69 (2005) 295-300
29. Choi I.S., Oh D.Y., Kwon J.H., Kim S.I., Park S.R., Bak J.Y., et al. Paclitaxel/platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer. Jpn J Clin Oncol 35 (2005) 6-12
30. O'Brien M.E., Splinter T., Smit E.F., Biesma B., Krzakowski M., Tjan-Heijnen V.C., et al. Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. An EORTC phase II study (EORTC 08958). Eur J Cancer 39 (2003) 1416-1422
31. Splinter T.A. Paclitaxel and carboplatin as neoadjuvant chemotherapy in operable (stages I and II) and locally advanced (stage IIIA-N2) non-small cell lung cancer. Semin Oncol 23 (1996) 59-61
32. Eberhardt W., Bildat S., Korfee S., and Stamatis G. Preoperative treatment strategies in stage III non-small cell lung cancer. Lung Cancer 33 suppl. 1 (2001) S51-S59
33. Thomas M., Macha H.N., Ukena D., Hamm M., Deppermann M., Semik M., et al. Cisplatin/etoposide (PE) followed by twice-daily chemoradiation (hfRT/CT) versus PE alone before surgery in stage III non-small cell lung cancer (NSCLC): a randomized phase III trial of the German Lung Cancer Cooperative Group (GLCCG). Proc Am Soc Clin Oncol 23 (2004) 616 (Abstract 7004)
34. Albain K.S., Scott C.B., Rusch V.R., Turrisi A.T., Shepherd F.A., Smith C., et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs. CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309). Proc Am Soc Clin Oncol 23 (2005) 624 (Abstract 7014)
35. Van Meerbeeck J., Kramer G., Van Schil P., Legrand C., and Smit E. A randomized trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941). Proc Am Soc Clin Oncol 23 (2005) 624 (Abstract 7015)